Decibel Therapeutics is based in Boston, MA. It has raised $341M in total funding. Latest round: Series C. Backed by GV, Third Rock Ventures, SR One.
Decibel Therapeutics is based in Boston, MA. Decibel Therapeutics has raised $341M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2018. The round record for Decibel Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include GV, Third Rock Ventures, SR One, Regeneron Pharmaceuticals, Foresite Capital, Bessemer Venture Partners and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for Decibel Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026